Form 4: Lantheus Holdings Chief Medical Officer Acquires Shares and Stock Options

Jeffrey Humphrey, Chief Medical Officer of Lantheus Holdings, acquired shares and stock options in the company on June 17, 2024.

Summary

• On June 17, 2024, Jeffrey Humphrey, the Chief Medical Officer of Lantheus Holdings, acquired 9,076 shares of common stock at a price of $82.63 per share.
• He also acquired 16,188 stock options with an exercise price of $82.63, vesting in three equal annual installments beginning June 17, 2025.
• Following these transactions, Humphrey directly owns 9,076 shares of Lantheus Holdings common stock and 16,188 stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting insider transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of shares and stock options by a key executive could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by the Chief Medical Officer.

Key Dates